Страна: Австралия
Език: английски
Източник: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PREDNISOLONE
MAVLAB PTY. LTD.
prednisolone(20mg/g)
ORAL GRANULES, PELLETS
PREDNISOLONE STEROID-GLUCOCORTICOID Active 20.0 mg/g
150g
VM - Veterinary Medicine
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
ENDOCRINE SYSTEM
CORTICOSTEROID | ADVANCING PARTURITION | ALLERGIC REACTIONS | ANTIADRENAL SUPPRESSION | ANTI-INFLAMMATORY | ANTISHOCK | ARTHRITIS | BRONCHITIS | CATABOLIC COMPLICATIONS | CHRONIC BRONCHITIS | CORTICOSTEROIDS | CORTICOSTEROIDS AND RELATE | COUGHS | DERMATITIS | DERMATOLOGICAL DISORDERS | DERMATOSES | ECZEMA | GLUCOGENIC STEROID | JOINT DISEASE | KETOSIS | LOCOMOTIVE DISEASES | MUSCULO SKELETAL INFLAMMAT | ORTHOPAEDIC | PARTURIENT UDDER OEDEMA | PARTURITION | PRURITIS | RESPIRATORY TRACT DISEASES | RHEUMATIC DISEASES | STRESS | TOXAEMIA | WATER RETENTION
Poison schedule: 4; Withholding period: WHP: DO NOT USE less than 28 days befor e slaughter for human consumption.; Host/pest details: HORSE: [CORTICOSTEROID]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [CORTICOSTEROID]; For the treatment of inflammatory and allergic conditions in horses.See product label for details.
Registered
2023-07-01
I Mavlab logo We Do Care 33 Rowland St., Slacks Creek, Qld 4127 For the treatment of inflammatory and allergic conditions in horses. ACTIVE CONSTITUENT: 20 mg/g PREDNISOLONE MACROLONE GRANULES Anti-Inflammatory, anti-allergy DIRECTIONS FOR USE: PRECAUTIONS AND CONTRAINDICATIONS: DO NOT administer to foals, stallions or pregnant mares; or to animals suffering laminitis, renal disease or corneal ulcers. The anti-inflammatory action may delay the healing of wounds and the repair of fractures, particularly in old animals. In racing animals this product must be withdrawn prior to racing in accordance with the rules of racing. DOSAGE AND ADMINISTRATION: Administer orally on alternate days at the rate of 200 mg Prednisolone/Sue kg bodyweight (J mg/2.5 kg) or 109 granules/500 kg bodyweight. 200 mg Prednisolone is contained in two slightly rounded measures of the measure provided. WITHHOLDING PERIOD: DO NOT USE less than 28 days before slaughter for human consumption. STORAGE: Store below 30°C (Room Temperature). Replace lid tightly after use. DISPOSAL: Dispose of container by wrapping in paper and putting in garbage NRA Approval Number: 37438/0:' \ ~ , Expiry Date Batch Number 150g PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY NET CONTENTS N.R.A" I APPROV~. ~ LABEL (lEXT) _.._ l Label No: ~!.~.:?~ j.9t 01 i Date: ? 3. .. .1 ~)(.'. '(Q~~' d Signature: .' .: _AtfR_ /~ .. ~ ·· .. f - 01 /. , . '~~l' • ..- . ... . ~"- . .. ~ , I Прочетете целия документ
MAVLAB PTY LTD Date of Issue: October 2007 MATERIAL SAFETY DATA SHEET MACROLONE GRANULES Page 1 of 5 MSDS version: 3 Date of Revision: October, 2007 Update of section: All sections SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER Product (material) name: Macrolone Granules Anti-Inflammatory Anti-Allergy Other names: Manufacturer's Code: P6600 Recommended use: Prednisolone granules are recommended for the treatment of inflammatory and allergic conditions in dogs, cats and horses. Supplier Details: Mavlab Pty Ltd ACN 068 507 148 33 Rowland Street SLACKS CREEK QLD 4127 Contact Person: Dr Paul Ross Emergency Telephone: (07) 3808 1399 Facsimile: (07) 3808 4328 SECTION 2 HAZARDS IDENTIFICATION This product is not dangerous goods under the Australian Dangerous Goods Code and is classified as not hazardous according to the classification criteria of NOHSC:1008(2004), Approved Criteria For Classifying Hazardous Substances and the National Code of Practice for the Preparation of Material Safety Data Sheets 2 nd Edition [NOHSC:2011(2003)]: Poisons Schedule: S4 Although this product contains Prednisolone which would be classified as hazardous according to the above criteria, the concentration of Prednisolone present in this material is below the concentration cut-off for classification of the product as hazardous. Health Effects Swallowed: May be harmful if swallowed Eye: Not expected to irritate the eyes. Skin: A single prolonged exposure is not likely to result in the material being absorbed through the skin in harmful amounts, however skin absorption may occur with prolonged exposure. Inhaled: Inhalation exposure under normal conditions of use is not likely to cause adverse effects, however it may occur with prolonged exposure. SECTION 3 COMPOSITION/INFORMATION ON INGREDIENTS INGREDIENTS Cas No. Proportion Prednisolone [57-24-8] < 14.0% Sucrose [57-50-1] <90.0% Starch-Maize [9005-25-8] < 60.0% Cellulose-Powdered [9004-34-6] < 15.0% Lactose-hydrous [63-42-3] < 30.0% Sodium Lauryl Sulphate [151-21-3] < 5.0% Sodium Sili Прочетете целия документ